|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 487/06 | |
| A61K 31/407 | |||
| A61P 25/00 |
| (11) | Patento numeris | 3288946 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16721320.6 |
| Europos patento paraiškos padavimo data | 2016-04-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-03-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-08-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/029308 |
| Data | 2016-04-26 |
| (87) | Numeris | WO 2016/176177 |
| Data | 2016-11-03 |
| (30) | Numeris | Data | Šalis |
| 201562153082 P | 2015-04-27 | US |
| (72) |
REN, Albert S., US
SEMPLE, Graeme, US
ZHU, Xiuwen, US
SAGE, Carleton R., US
|
| (73) |
Arena Pharmaceuticals, Inc.,
6154 Nancy Ridge Drive, San Diego, CA 92121,
US
|
| (54) | 5-HT2C RECEPTOR AGONISTS AND COMPOSITIONS AND METHODS OF USE |
| 5-HT2C RECEPTOR AGONISTS AND COMPOSITIONS AND METHODS OF USE |